Canada markets closed

Ampio Pharmaceuticals, Inc. (AMPE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2550+0.0030 (+1.19%)
At close: 12:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 289.52k
Enterprise Value -3.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.09
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 1.95
52-Week Change 3-94.46%
S&P500 52-Week Change 322.38%
52 Week High 38.2980
52 Week Low 30.1350
50-Day Moving Average 31.0430
200-Day Moving Average 32.3892

Share Statistics

Avg Vol (3 month) 358.88k
Avg Vol (10 day) 34.88k
Shares Outstanding 51.14M
Implied Shares Outstanding 61.14M
Float 81.12M
% Held by Insiders 11.56%
% Held by Institutions 14.19%
Shares Short (Mar 28, 2024) 432.9k
Short Ratio (Mar 28, 2024) 40.31
Short % of Float (Mar 28, 2024) 42.94%
Short % of Shares Outstanding (Mar 28, 2024) 42.90%
Shares Short (prior month Feb 29, 2024) 434.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Sept 12, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-61.57%
Return on Equity (ttm)-113.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -9.39M
Net Income Avi to Common (ttm)-8.63M
Diluted EPS (ttm)-10.6600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.12M
Total Cash Per Share (mrq)3.63
Total Debt (mrq)451k
Total Debt/Equity (mrq)13.42%
Current Ratio (mrq)2.41
Book Value Per Share (mrq)4.03

Cash Flow Statement

Operating Cash Flow (ttm)-8.56M
Levered Free Cash Flow (ttm)-5.37M